ÂÜÀòÂÒÂ×

Theodore Martinot is an accomplished professional in the pharmaceutical industry with extensive experience in chemistry and drug development. Currently serving as Vice President, CMC at MapLight Therapeutics, Inc. since September 2024, Martinot previously held the position of Vice President of Pharmaceutical Development at FogPharma, where responsibilities included building and leading the pharmaceutical development function. Prior roles include Senior Director of Chemistry at Infinity Pharmaceuticals, where critical oversight of departmental functions occurred, and Principal Scientist at Merck, contributing to neuroscience, inflammation, and oncology projects. Martinot has a robust educational foundation with a PhD in Organic Chemistry from the University of Florida, a PostDoc from the University of North Carolina at Chapel Hill, and dual degrees in Chemistry and French from the University of Florida, graduating with highest and high honors, respectively.